Victory Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $162M | Buy |
4,491,680
+868,546
| +24% | +$31.3M | 0.1% | 210 |
|
|
2025
Q1 | $113M | Buy |
3,623,134
+2,644,923
| +270% | +$82.3M | 0.12% | 199 |
|
|
2024
Q4 | $25M | Buy |
978,211
+129,176
| +15% | +$3.3M | 0.02% | 759 |
|
|
2024
Q3 | $24M | Buy |
849,035
+179,411
| +27% | +$5.08M | 0.02% | 784 |
|
|
2024
Q2 | $17.7M | Buy |
669,624
+211,131
| +46% | +$5.57M | 0.02% | 851 |
|
|
2024
Q1 | $13.9M | Buy |
458,493
+192,782
| +73% | +$5.85M | 0.01% | 943 |
|
|
2023
Q4 | $7.46M | Sell |
265,711
-73,179
| -22% | -$2.06M | 0.01% | 1151 |
|
|
2023
Q3 | $9.2M | Buy |
338,890
+28,851
| +9% | +$783K | 0.01% | 1048 |
|
|
2023
Q2 | $9.53M | Buy |
310,039
+23,960
| +8% | +$737K | 0.01% | 1062 |
|
|
2023
Q1 | $10.3M | Buy |
286,079
+17,535
| +7% | +$632K | 0.01% | 1019 |
|
|
2022
Q4 | $10.6M | Buy |
268,544
+9,221
| +4% | +$364K | 0.01% | 1003 |
|
|
2022
Q3 | $10.4M | Buy |
259,323
+102,847
| +66% | +$4.13M | 0.01% | 1054 |
|
|
2022
Q2 | $6.58M | Sell |
156,476
-13,367
| -8% | -$562K | 0.01% | 1186 |
|
|
2022
Q1 | $7.23M | Buy |
169,843
+135,102
| +389% | +$5.75M | 0.01% | 1214 |
|
|
2021
Q4 | $1.38M | Sell |
34,741
-55,183
| -61% | -$2.2M | ﹤0.01% | 1685 |
|
|
2021
Q3 | $3.25M | Sell |
89,924
-1,164,574
| -93% | -$42.1M | ﹤0.01% | 1448 |
|
|
2021
Q2 | $51.4M | Sell |
1,254,498
-1,933,796
| -61% | -$79.3M | 0.05% | 555 |
|
|
2021
Q1 | $139M | Sell |
3,188,294
-519,438
| -14% | -$22.7M | 0.14% | 175 |
|
|
2020
Q4 | $186M | Buy |
3,707,732
+866,849
| +31% | +$43.4M | 0.21% | 104 |
|
|
2020
Q3 | $120M | Sell |
2,840,883
-410,227
| -13% | -$17.3M | 0.15% | 172 |
|
|
2020
Q2 | $158M | Buy |
+3,251,110
| New | +$158M | 0.21% | 107 |
|